Latest Breaking News On - ஐரோப்பிய இதயம் இதழ் - Page 9 : comparemela.com

European Society of Cardiology Sophia Antipolis, 23 June 2021 : Statin use among patients with heart failure is associated with a 16% lower risk of developing cancer compared with non-statin users during an average of four years of follow-up, according to new research published today (Wednesday) in the European Heart Journal [1]. In addition, the study found that statin use was associated with a 26% reduced risk of dying from cancer over the same period. Previous research has shown that heart failure patients are at increased risk of developing cancer, possibly because heart failure may be a cancer-causing condition via shared pathways such as inflammation or genetic factors. However, there has been very little study of the associations between statin use and the risk of developing and dying from cancer in patients with heart failure. The current observational study of over 87,000 people in Hong Kong is the largest study to investigate this and the authors believe their findings

Hong kongUniversity of hong kongHong kong generalSophia antipolisNational heart centerEuropean heart journalKai hang yiuProfessor carolyn lamஹாங் காங்பல்கலைக்கழகம் ஆஃப் ஹாங் காங்ஹாங் காங் ஜநரல்தேசிய இதயம் மையம்ஐரோப்பிய இதயம் இதழ்ப்ரொஃபெஸர் கரோலின் லாம்